These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26199396)

  • 41. Effectiveness of lymphocytapheresis in a patient with ankylosing spondylitis.
    Ueo T; Kobori K; Okumura H; Ito K; Yoshida H; Norioka M; Shimizu K; Yamamuro T
    Transfus Sci; 1990; 11(1):97-101. PubMed ID: 10149524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thymic humoral factor effect on intracellular lymphocyte cAMP in patients with ankylosing spondylitis.
    Mutchnick MG; Good AE; Barlas N; Trainin N
    J Rheumatol; 1982; 9(4):627-9. PubMed ID: 6290660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface.
    De Keyser F; Mielants H
    J Rheumatol; 2003 Nov; 30(11):2306-7. PubMed ID: 14677167
    [No Abstract]   [Full Text] [Related]  

  • 44. HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707.
    Varnavidou-Nicolaidou A; Karpasitou K; Georgiou D; Stylianou G; Kokkofitou A; Michalis C; Constantina C; Gregoriadou C; Kyriakides G
    Hum Immunol; 2004 Dec; 65(12):1451-4. PubMed ID: 15603872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation of HLA-B27, tumor necrosis factor-α promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis -- a comprehensive genotype-phenotype analysis from an observational cohort.
    Poddubnyy DA; Märker-Hermann E; Kaluza-Schilling W; Zeidler H; Braun J; Listing J; Sieper J; Rudwaleit M
    J Rheumatol; 2011 Nov; 38(11):2436-41. PubMed ID: 21885496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A collection of chemical biology strategies for visualization in live cells.
    Dey M
    Cell Chem Biol; 2022 Jan; 29(1):1-2. PubMed ID: 35063065
    [No Abstract]   [Full Text] [Related]  

  • 47. Absence of Antienterobacteriaceae and anti-HLA-B27 antibodies in mitogen stimulated cultures of lymphocytes from patients with Reiter's syndrome and ankylosing spondylitis.
    Cavender DE; Ziff M
    J Rheumatol; 1988 Feb; 15(2):315-20. PubMed ID: 3258921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulatory IL4+CD8+ T cells in patients with ankylosing spondylitis and healthy controls.
    Zhang L; Jarvis LB; Baek HJ; Gaston JS
    Ann Rheum Dis; 2009 Aug; 68(8):1345-51. PubMed ID: 18647857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomedicine. Puzzling out the pains in the gut.
    Marx J
    Science; 2007 Jan; 315(5808):33-5. PubMed ID: 17204619
    [No Abstract]   [Full Text] [Related]  

  • 50. Animal models of spondyloarthritis.
    Lories RJ
    Curr Opin Rheumatol; 2006 Jul; 18(4):342-6. PubMed ID: 16763452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spondyloarthritis: Gut inflammation in SpA: flagellin joins the dance?
    Jacques P; Elewaut D
    Nat Rev Rheumatol; 2014 Jan; 10(1):5-6. PubMed ID: 24323068
    [No Abstract]   [Full Text] [Related]  

  • 52. Spondyloarthropathies: Gut dysbiosis in ankylosing spondylitis.
    Barranco C
    Nat Rev Rheumatol; 2015 Jan; 11(1):1. PubMed ID: 25486979
    [No Abstract]   [Full Text] [Related]  

  • 53. Interleukin-1: a new therapeutic target for ankylosing spondylitis?
    Wendling D
    Joint Bone Spine; 2005 Oct; 72(5):357-8. PubMed ID: 16214068
    [No Abstract]   [Full Text] [Related]  

  • 54. New immune cells in spondyloarthritis: Key players or innocent bystanders?
    Venken K; Elewaut D
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):706-14. PubMed ID: 27107508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis.
    Cypers H; Varkas G; Beeckman S; Debusschere K; Vogl T; Roth J; Drennan MB; Lavric M; Foell D; Cuvelier CA; De Vos M; Delanghe J; Van den Bosch F; Elewaut D
    Ann Rheum Dis; 2016 Jul; 75(7):1357-62. PubMed ID: 26698844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expanded IL-22
    Min HK; Moon J; Lee SY; Lee AR; Lee CR; Lee J; Kwok SK; Cho ML; Park SH
    Immune Netw; 2021 Dec; 21(6):e43. PubMed ID: 35036030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights.
    Qaiyum Z; Lim M; Inman RD
    Semin Immunopathol; 2021 Apr; 43(2):173-192. PubMed ID: 33625549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Innate lymphoid cells in inflammatory arthritis.
    Fang W; Zhang Y; Chen Z
    Arthritis Res Ther; 2020 Feb; 22(1):25. PubMed ID: 32051038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ILC3 in Axial Spondyloarthritis: the Gut Angle.
    Mauro D; Macaluso F; Fasano S; Alessandro R; Ciccia F
    Curr Rheumatol Rep; 2019 Jun; 21(7):37. PubMed ID: 31197599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting inflammatory pathways in axial spondyloarthritis.
    Furst DE; Louie JS
    Arthritis Res Ther; 2019 Jun; 21(1):135. PubMed ID: 31164157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.